Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women

Stopped early · Not applicable

Conditions studied: Preterm Labor, Preterm Birth

In brief

The study is to evaluate the accuracy of a test device called "PAMG-1" to see if a pregnant women has ruptured membranes in comparison to standardly used testing methods.

Key facts

Study ID

NCT03715530

Run by

Mark Santillan

People needed

162

Starts

2007-09-01

Expected to finish

2011-07-01

Last updated by the study team

2019-10-03

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• women 18 to 50 years of age
• being seen at the University of Iowa Women's Healthcare Clinic

You may not qualify if…

• men

Where it is running

• University of Iowa — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.